These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 36271889)

  • 41. Interaction of target cell-bound C3bi and C3d with human lymphocyte receptors. Enhancement of antibody-mediated cellular cytotoxicity.
    Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
    J Exp Med; 1981 Jun; 153(6):1592-603. PubMed ID: 7252421
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation.
    Liszewski MK; Kolev M; Le Friec G; Leung M; Bertram PG; Fara AF; Subias M; Pickering MC; Drouet C; Meri S; Arstila TP; Pekkarinen PT; Ma M; Cope A; Reinheckel T; Rodriguez de Cordoba S; Afzali B; Atkinson JP; Kemper C
    Immunity; 2013 Dec; 39(6):1143-57. PubMed ID: 24315997
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interplay between fibrinolysis and complement: plasmin cleavage of iC3b modulates immune responses.
    Foley JH; Peterson EA; Lei V; Wan LW; Krisinger MJ; Conway EM
    J Thromb Haemost; 2015 Apr; 13(4):610-8. PubMed ID: 25556624
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Participation of C3 and its ligands in complement activation.
    Volanakis JE
    Curr Top Microbiol Immunol; 1990; 153():1-21. PubMed ID: 2404692
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of monoclonal anti-C3 antibodies to characterise the fragments of C3 that are found on erythrocytes.
    Lachmann PJ; Voak D; Oldroyd RG; Downie DM; Bevan PC
    Vox Sang; 1983; 45(5):367-72. PubMed ID: 6605620
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
    Sahu A; Kay BK; Lambris JD
    J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evidence for three binding sites for C3 (hemolytically inactive), C3b and C3d on a CR2-positive Burkitt lymphoma-derived cell line (Raji).
    Barile G; Di Renzo L; Lipari M; Frati L; Faggioni A
    FEBS Lett; 1993 Jun; 324(3):319-24. PubMed ID: 8405374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Binding of C3 and C3dg to the CR2 complement receptor induces growth of an Epstein-Barr virus-positive human B cell line.
    Hatzfeld A; Fischer E; Levesque JP; Perrin R; Hatzfeld J; Kazatchkine MD
    J Immunol; 1988 Jan; 140(1):170-5. PubMed ID: 2826586
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activation of rabbit C3: studies of the generation of cleavage products in vitro and of their metabolism in vivo.
    Peake PW; Charlesworth JA; Pussell BA
    Complement Inflamm; 1991; 8(5-6):261-70. PubMed ID: 1802545
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.
    Medof ME; Iida K; Mold C; Nussenzweig V
    J Exp Med; 1982 Dec; 156(6):1739-54. PubMed ID: 7175439
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparative evaluation of receptor reactivities for C3b, iC3b, and C3d on Raji lymphoblastoid cells.
    Scheiner O; Hammann KP; Schmid HU; Schulz T; Alsenz J; Dierich MP
    Int Arch Allergy Appl Immunol; 1982; 69(3):231-7. PubMed ID: 6215359
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of C3 deposition and degradation on bacterial surfaces after opsonization.
    Gordon DL; Rice J; Finlay-Jones JJ; McDonald PJ; Hostetter MK
    J Infect Dis; 1988 Apr; 157(4):697-704. PubMed ID: 3279137
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Complement fragments C3b and iC3b coupled to latex induce a respiratory burst in human neutrophils.
    Hoogerwerf M; Weening RS; Hack CE; Roos D
    Mol Immunol; 1990 Feb; 27(2):159-67. PubMed ID: 2138709
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interaction of fibronectin with complement component C3.
    Hautanen A; Keski-Oja J
    Scand J Immunol; 1983 Mar; 17(3):225-30. PubMed ID: 6402811
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Two conformational forms of target-bound iC3b that distinctively bind complement receptors 1 and 2 and two specific monoclonal antibodies.
    Nilsson UR; Funke L; Nilsson B; Ekdahl KN
    Ups J Med Sci; 2011 Mar; 116(1):26-33. PubMed ID: 21070093
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preimplantation embryos cooperate with oviductal cells to produce embryotrophic inactivated complement-3b.
    Tse PK; Lee YL; Chow WN; Luk JM; Lee KF; Yeung WS
    Endocrinology; 2008 Mar; 149(3):1268-76. PubMed ID: 18039777
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement.
    Pangburn MK; Müller-Eberhard HJ
    J Exp Med; 1980 Oct; 152(4):1102-14. PubMed ID: 6903192
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structural insights on complement activation.
    Alcorlo M; López-Perrote A; Delgado S; Yébenes H; Subías M; Rodríguez-Gallego C; Rodríguez de Córdoba S; Llorca O
    FEBS J; 2015 Oct; 282(20):3883-91. PubMed ID: 26250513
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Third component of human complement: C3.
    Berger M
    Methods Enzymol; 1990; 184():619-28. PubMed ID: 2143801
    [No Abstract]   [Full Text] [Related]  

  • 60. Opsonization of yeast cells with equine iC3b, C3b, and IgG.
    Gröndahl G; Johannisson A; Jensen-Waern M; Nilsson Ekdahl K
    Vet Immunol Immunopathol; 2001 Aug; 80(3-4):209-23. PubMed ID: 11457475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.